MyMD Pharmaceuticals, Inc. - Common Stock (NQ:MYMD)

1.820 UNCHANGED

Last Price Updated: 3:38 PM EDT, Jul 23, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MyMD Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

MyMD Pharmaceuticals® Provides Dosing Update on Phase 2 Multi-Center Clinical Trial of MYMD-1® as a Therapy for Delaying Aging and Extending Healthy Lifespan

April 12, 2023

From MyMD Pharmaceuticals, Inc.

Via Business Wire

MyMD Pharmaceuticals® and Charles River Present Positive Data for Next Generation, Oral TNF-α Inhibitor MYMD-1® in Rheumatoid Arthritis

March 20, 2023

From MyMD Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 10, 2023

Via Benzinga

MyMD Joins LOT Network To Protect Company And Shareholders From Patent Trolls ↗

March 08, 2023

MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) has joined LOT Network, the international, non-profit community of companies working together to protect themselves against litigation brought on by patent...

Via Benzinga

MyMD Joins LOT Network in Effort to Protect Company and Shareholders from Patent Trolls

March 08, 2023

From MyMD Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 03, 2023

Via Benzinga

DEA Concludes MyMD's Supera-CBD Is Not A Controlled Substance Or Listed Chemical ↗

March 02, 2023

MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) announced that the U.S. Drug Enforcement Administration has conducted a scientific review and determined that investigational cannabinoid Supera-CBD is not...

Via Benzinga

MyMD Announces U.S. Drug Enforcement Administration (DEA) Determines Supera-CBD™ is not a Controlled Substance or Listed Chemical

March 02, 2023

From MyMD Pharmaceuticals, Inc.

Via Business Wire

MyMD Pharmaceuticals® Announces Upcoming Presentation of Preclinical Rheumatoid Arthritis Data for Oral TNF-α Inhibitor MYMD-1® at the Society of Toxicology 2023 Annual Meeting

February 28, 2023

From MyMD Pharmaceuticals, Inc.

Via Business Wire

MyMD Announces $15 Million Offering with Existing Investors

February 21, 2023

From MyMD Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 15, 2023

Via Benzinga

Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 14, 2023

Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.

Via Benzinga

Why AppTech Payments Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 31, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 31, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 30, 2023

Via Benzinga

Why Heart Test Laboratories Are Trading Higher By 136%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 30, 2023

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 136% to $2.06 after Ascendant Capital initiated coverage on the stock with a Buy rating and a $3.30 price target.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 16, 2023

Via Benzinga

ADDING MULTIMEDIA MyMD Pharmaceuticals® to Present Data on Oral TNF-a Inhibitor MYMD-1® at the British Society for Immunology (BSI) Congress 2022

December 06, 2022

From MyMD Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 23, 2022

Via Benzinga

MyMD Pharmaceuticals® Announces Upcoming Presentation of Late-Breaking Data for MYMD-1® at the 2022 British Society for Immunology (BSI) Congress

November 17, 2022

From MyMD Pharmaceuticals, Inc.

Via Business Wire

MyMD Pharmaceuticals Announces Publication of Phase 1 Data for oral TNF-alpha Inhibitor MYMD-1® in Peer-Reviewed Journal Drug Research

November 14, 2022

From MyMD Pharmaceuticals, Inc.

Via Business Wire

October 04, 2022

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per...

Via Benzinga

Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday ↗

September 27, 2022

Gainers

Via Benzinga

Why LAVA Therapeutics Shares Are Trading Higher By 97%, Here Are 49 Stocks Moving In Monday's Mid-Day Session ↗

September 26, 2022

Gainers

Via Benzinga

MyMD Pharmaceuticals® Provides Dosing Update on Phase 2 Multi-Center Clinical Trial of MYMD-1® as a Therapy for Delaying Aging and Extending Healthy Lifespan

September 20, 2022

From MyMD Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 01, 2022

Gainers SenesTech (NASDAQ:SNES) stock rose 28.0% to $0.64 during Thursday's after-market session. The market value of their outstanding shares is at $7.8 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 31, 2022

Via Benzinga

MyMD Pharmaceuticals Receives Grant From European Patent Office for Supera-CBD™ Compound

August 30, 2022

From MyMD Pharmaceuticals, Inc.

Via Business Wire

This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday ↗

August 16, 2022

Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.